Robin Howe
Papers
1
Total Citations
170
H-Index
1
About
Robin Howe is a leading researcher in antimicrobial resistance and nanomedicine, whose work addresses one of modern medicine’s most pressing crises: the rise of drug-resistant pathogens. Her major contributions center on developing innovative strategies to overcome antibiotic resistance, most notably through the use of alginate oligosaccharides as nanomedicine agents. Her landmark 2012 paper, “Overcoming Drug Resistance with Alginate Oligosaccharides Able To Potentiate the Action of Selected Antibiotics,” has garnered over 170 citations, demonstrating its significant impact on the field. In this work, Howe and her team demonstrated how low-molecular-weight oligosaccharides can restore the efficacy of conventional antibiotics against resistant bacterial strains, offering a promising alternative to traditional drug development. By targeting the mechanisms pathogens use to evade treatment, her research provides a scalable, cost-effective approach to combating superbugs—a critical need given the billions of dollars in healthcare costs linked to resistance. Howe’s work bridges fundamental microbiology and applied therapeutics, making her a pivotal figure in the fight to preserve antibiotic effectiveness for future generations.
Research Focus
Key Achievements
Top Papers
- 1